Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Cancer Prev. 2011 Mar;20(2):77-85. doi: 10.1097/CEJ.0b013e328341e371.

p53: its alteration and gallbladder cancer.

Author information

  • 1Department of Surgical Oncology, Institute of Medical Sciences, Faculty of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

Abstract

Gallbladder cancer (GBC) is the most common malignancy of the biliary tract. Despite the recent advancements in the understanding of cancer biology the disease still remains a therapeutic challenge with poor survival, and with early surgical resection as the only powerful treatment. Understanding the molecular events in gallbladder carcinogenesis may provide a novel targeted therapeutic approach. Of these, alterations in the tumour suppressor gene, p53, are commonly observed in most human cancers. However, its impact on the pathogenesis of GBC remains obscure. This study attempts to outline the p53 structure, function and its alterations, with special attention to GBC.

PMID:
21131824
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk